{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:37:41Z","timestamp":1792816661904,"version":"4.5.0"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7886-26","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:11:33Z","timestamp":1792620693000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Autosomal Dominant Alport Syndrome with Normal Type IV Collagen \u03b15 Staining Diagnosed by a Genetic Analysis"],"prefix":"10.2169","author":[{"given":"Fuya","family":"Tanno","sequence":"first","affiliation":[{"name":"Department of Nephrology and Rheumatology, Saiseikai Niigata Kenoh Kikan Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Iwafuchi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Saiseikai Niigata Kenoh Kikan Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naofumi","family":"Imai","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University Graduate School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cosgrove D, Liu S. Collagen IV diseases: a focus on the glomerular basement membrane in Alport syndrome. Matrix Biol 57-58: 45-54, 2017.","DOI":"10.1016\/j.matbio.2016.08.005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kashtan CE, Ding J, Garosi G, et al. Alport syndrome: a unified classification of genetic disorders of collagen IV a345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int 93: 1045-1051, 2018.","DOI":"10.1016\/j.kint.2017.12.018"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lee KB, Jung M, Lim BJ. Pathological diagnosis of Alport syndrome. Kidney Res Clin Pract 44: 406-410, 2025.","DOI":"10.23876\/j.krcp.24.063"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bernstein J. The glomerular basement membrane abnormality in Alport\u2019s syndrome. Am J Kidney Dis 10: 222-229, 1987.","DOI":"10.1016\/S0272-6386(87)80177-4"},{"key":"5","unstructured":"5. Nozu K, Yamamura T, Horinouchi T. Alport Syndrome. In: GeneReviews<sup>\u24c7<\/sup> Adam MP, Bick S, Mirzaa GM, et al., Eds. [Internet]. Seattle, 2025: 1993-2026."},{"key":"6","unstructured":"6. Yoshioka K, Hino S, Takemura T, et al. Type IV collagen alpha 5 chain. normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 144: 986-996, 1994."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nozu K, Nakanishi K, Abe Y, et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol 23: 158-168, 2019.","DOI":"10.1007\/s10157-018-1629-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY. Thin basement membrane nephropathy. Kidney Int 64: 1169-1178, 2003.","DOI":"10.1046\/j.1523-1755.2003.00234.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kashtan CE. Alport syndrome: achieving early diagnosis and treatment. Am J Kidney Dis 77: 272-279, 2021.","DOI":"10.1053\/j.ajkd.2020.03.026"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Betsikos A, Paschou E, Geladari V, Gazouni E, Sabanis N. An elusive diagnosis of autosomal dominant Alport syndrome: genomic sequencing is a game changer. Cureus 17: e94077, 2025.","DOI":"10.7759\/cureus.94077"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Savige J, Storey H, Watson E, et al. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. Eur J Hum Genet 29: 1181-1195, 2021.","DOI":"10.1038\/s41431-021-00858-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Marcocci E, Uliana V, Bruttini M, et al. Autosomal dominant Alport syndrome: clinical outcome and COL4A4 mutations. Nephrol Dial Transplant 24: 1463-1468, 2009.","DOI":"10.1093\/ndt\/gfn681"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Furlano M, Martinez V, Pybus M, et al. Clinical and genetic features of autosomal dominant Alport syndrome: a cohort study. Am J Kidney Dis 78: 560-570.e1, 2021.","DOI":"10.1053\/j.ajkd.2021.02.326"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Akihisa T, Sato M, Wakayama Y, et al. Glomerular basement membrane protein expression and the diagnosis and prognosis of autosomal dominant Alport syndrome. Kidney Med 1: 391-396, 2019.","DOI":"10.1016\/j.xkme.2019.06.007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yamamura T, Horinouchi T, Nagano C, et al. Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome. Kidney Int 98: 1605-1614, 2020.","DOI":"10.1016\/j.kint.2020.06.038"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gross O, Licht C, Anders HJ, et al. Early ACE inhibition delays renal failure and improves life expectancy in Alport syndrome. Kidney Int 81: 494-501, 2012.","DOI":"10.1038\/ki.2011.407"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Boeckhaus J, Gale DP, Simon J, et al. SGLT2-inhibition in patients with Alport syndrome. Kidney Int Rep 9: 3490-3500, 2024.","DOI":"10.1016\/j.ekir.2024.09.014"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Reiterov\u00e1 J, Tesa\u0159 V. Current and future therapeutical options in Alport syndrome. Int J Mol Sci 24: 5522, 2023.","DOI":"10.3390\/ijms24065522"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Reiterov\u00e1 J, Tesa\u0159 V. Current and future therapeutical options in Alport syndrome. Int J Mol Sci 24: 5522, 2023.","DOI":"10.3390\/ijms24065522"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lo Re C, Kim JJ, Fornoni A. From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome. Pediatr Nephrol 41: 607-619, 2026.","DOI":"10.1007\/s00467-025-07046-z"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 24: 364-375, 2013.","DOI":"10.1681\/ASN.2012020148"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7886-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:13:09Z","timestamp":1792815189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7886-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":21,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7886-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7886-26"}}